NMN Rescued Brain Aging and Strengthened the Gut in Mice

Methods

60 male mice were divided into five groups:

• Control: No D-galactose or NMN received for 8 weeks
• D-gal: Injected with 200 mg/kg/day D-galactose for 8 weeks
• NMN250: D-gal + 250 mg/kg/day NMN by oral gavage for 8 weeks
• NMN500: D-gal + 500 mg/kg/day NMN by oral gavage for 8 weeks
• Ex527: D-gal + 500 mg/kg/day NMN by oral gavage, plus 5 mg/kg Ex527 (Sirt1 inhibitor) for 8 weeks

"The aging model was induced by subcutaneous administration of D-gal (200 mg/kg/day) in all groups except the Control group."

NMN Improved Memory and Reduced Brain Stress

The aging treatment made the mice slower and impaired their memory. NMN reversed those changes. Mice moved more and performed better on memory tests.

"Increase in locomotor activity as evidenced by a greater total distance traveled and higher moving speed in aging mice… Suggest that NMN enhances both motor function and locomotor activity in aged mice."

NMN boosted the mice's natural antioxidant defenses, helping rebalance this internal stress and protect brain cells by lowering oxidative stress (OS).

"Reduction in all these OS biomarkers… increased [antioxidant enzymes] serum levels, and brain expression, indicating a substantial enhancement in endogenous antioxidant defense mechanisms."

Inflammation was also reduced, helping calm the chronic inflammatory environment that often accompanies aging.

"Reduction in the expression of inflammatory markers in aging mice, including AGEs, TNF-α, IL-1β, and IL-6… suggesting that NMN effectively mitigates the inflammatory response associated with aging."

NMN also shifted key brain chemicals involved in mood and signaling.

"NMN… Increase in the levels of NE, serotonin, glutamic acid, and GABA, suggesting a potential enhancement of the balance between monoaminergic and excitatory/inhibitory neurotransmitter systems."

These results suggest that NMN can influence brain chemistry in aging and may help counteract and restore the balance between ROS and antioxidants, major drivers of chronic disease.

NMN Reduced Cellular Aging and Supported Mitochondria

The aging model increased p16 and p21, proteins linked to cellular aging. NMN lowered them.

"NMN… reduced the expression levels of p16 and p21 in brain tissue from aging mice… This downregulation suggests a potential inhibitory effect of NMN on molecular markers of cellular aging."

NMN also strengthened mitochondrial signaling, the system that helps cells produce energy efficiently and stay resilient under stress.

"NMN… upregulated the expression of Sirt1, p-AMPK, and PGC1α in the brains of aging mice… which is central to the enhancement of mitochondrial biogenesis and cellular energy homeostasis."

In addition, NMN reduced cell death in the brain. This helped preserve the structure and integrity of brain tissue.

"NMN doses of 250 and 500 mg/kg effectively reduced apoptotic cell proportions, directly confirming its neuroprotective efficacy."

This Sirt1–AMPK–PGC-1α axis is a core longevity pathway that governs mitochondrial biogenesis and stress adaptation and may help restore cellular resilience.

NMN Restored the Intestinal Barrier

Aging disrupted the colon lining and reduced mucus-producing goblet cells. NMN repaired much of that damage.

"NMN… preserved mucosal integrity, maintained the organization of goblet cells, and prevented epithelial cell shedding… suggesting a restorative effect of NMN on the colonic epithelial barrier."

Goblet cells also saw an increase.

"Increase in the number of goblet cells in the colons of NMN-treated mice… essential for maintaining mucosal integrity and barrier function."

Because the gut and brain communicate constantly through the gut–brain axis, improving intestinal health may also support brain function.

The Sirt1 Connection

Sirt1 activation is central to nearly every benefit observed from NMN supplementation. Across all the study results, the Ex527 group saw reduced and inhibited benefits.

"Crucially, all benefits were abolished by Sirt1 inhibition, confirming pathway specificity."

Together, the data point to Sirt1 as the central driver of NMN therapeutic benefits. This confirms that NMN is closely tied to Sirt1 activation.

Olivia Harrier

Learn More

Olivia is a biochemist and longevity researcher focused the molecular architecture of aging. Her work centers on metabolic health and the systems-level mechanisms that shape how we age. She translates dense research into clear frameworks for improving energy, resilience, and long-term health, grounded in physiology and evidence-driven frameworks that help people align daily habits with cellular performance. If you understand how the system works, you can work with it, and aging becomes something to navigate rather than just endure.